News

PillDrill named ‘Best New Product’ at ECRM’s Home Health Care EPPS event

BY Michael Johnsen
From left: DSN area manager Alex Tomas, Jacob Guernsey, creative director, PillDrill; Peter Havas, CEO, PillDrill; Dennis Gurka, director sales, PillDrill; Michael Castillo, SVP pharmacy/medical markets, ECRM
DALLAS — PillDrill won this year’s Drug Store News/ECRM Most Innovative Product Award for the Home Health Care category at ECRM’s Home Health Care EPPS event, held here Feb. 21 to 24.
Buyers cast votes on product innovation and packaging, and the winning product was selected from approximately 20 entries.
PillDrill was developed to be a smart, friendly medication tracking system that simplifies the task of everyday pill taking. It gives reminders when pills need to be taken, tracks what’s being taken with a quick scan and sends real-time adherence updates to those people involved in the patients’ well-being.
“We learned early on that medication adherence is not a technology problem, it’s a human problem,” said Peter Havas, CEO PillDrill. “So what makes PillDrill special is that it’s completely user-centric. It’s not some complicated piece of hardware, and it’s not an app; those things don’t really work for people in their everyday context,” Havas noted.
Instead, PillDrill is a light overlay onto an existing routine that provides all the benefits of a technology product without any of the hassles. “Through the simple act of scanning, we’ve made a product that’s easy enough for anyone to use, smart enough to help anyone and so fundamentally intuitive that we believe it can transform the whole issue of adherence for everyday people,” Havas added.
In related news, Logan, Utah-based Stander won the Best Room Award at ECRM’s Home Health Care EPPS event.
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

CHPA names chairman and chair-elect

BY Michael Johnsen
AVENTURA, Fla. – The Consumer Healthcare Products Association on Wednesday announced the elected officers and members to its board of directors at the association’s Annual Executive Conference here. Patrick Lockwood-Taylor,VP personal health care North America and digestive wellness design for Procter & Gamble will continue to serve as chair. Jeffrey Needham, EVP and general manager, U.S. Consumer Healthcare, Perrigo, was elected to the position of chair-elect and will take over as chair of CHPA in March, 2017.
 
“CHPA is privileged to have both Patrick and Jeff serving in leadership roles at our association,” stated Scott Melville, CHPA president and CEO. “Their keen business sense, collaborative nature and years of association involvement will help strengthen CHPA and its efforts to promote consumer empowerment through self-care.”
 
One-third of the CHPA board of directors is elected annually. Manufacturer members are elected for three-year terms, and associate members are elected for two-year terms. 
 
The re-elected board members as of this election are:
 
  • Christopher Ascher, co-president, B.F. Ascher & Company;
  • J.P. Borneman, chairman and CEO, Hyland’s;
  • Michael Donnantuono, president and COO, Blistex;
  • Stephen Fritz, head of OTC business, Purdue Pharma;
  • Jeffery Gerchenson, chairman and CEO, Alva-Amco Pharmacal Companies;
  • John Incledon, president and CEO, Hisamitsu America;
  • Alexander Lacik, president, North America, Reckitt Benckiser;
  • Mitchell Singer, CEO PL Developments;
  • Christopher Slager, regional president, North America, Pfizer Consumer Healthcare;
  • Akiyoshi Yoshida, president and CEO The Mentholatum Company; and
  • Richard Zulman, CEO BestCo.
 
The newly elected board members as of this election are:
 
  • Janick Boudazin, president and CEO Boiron;
  • Gregory Bradley, CEO Foundation Consumer Healthcare;
  • Stephen Fritz, head of OTC business, Purdue Pharma;
  • Meredith Guerriero, director, Facebook Health, Facebook;
  • Robert Sanders Jr., EVP and practice leader, IRI; and
  • Jennifer Willey, VP, consumer markets, WebMD. 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

CDC’s opioid prescribing guideline earns APhA support

BY David Salazar
ATLANTA — The Centers for Disease Control and prevention recently released its 2016 opioid prescribing guidelines, aimed at prescribers who recommend opioids for chronic pain outside of cancer treatment, end-of-life care and palliative care, and recommend collaborations with other healthcare professionals, including pharmacists. 
 
Among the guidelines are the recommendations that primary car physicians first turn to non-opioid therapy as a preferred treatment for chronic pain; that they provide the lowest effective immediate dose when they do use opioids; and that they work with patients to establish pain treatment goals, tailoring the treatment to the patient and discontinuing opioids when benefits don’t outweigh the risks. 
 
The guideline has earned praise from the American Pharmacists Association. 
 
“The CDC’s decision to release the guidelines is consistent with other public and private efforts that aim to curb prescription drug abuse while attempting to balance patient access to medically necessary treatment,” APhA associate director of health policy said. “Given the sheer number of Americans living with pain, policy changes and guidelines that influence treatment decisions will have far-reaching consequences.”
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?